FDA Forms Nanotechnology Task Force To Assess Technology
This article was originally published in The Rose Sheet
Executive Summary
FDA's Nanotechnology Task Force will identify policy gaps related to the use of nanotechnology particles to evaluate possible adverse health effects from products that contain the materials, the agency said